Molecule Details
InChIKeyDFJSJLGUIXFDJP-UHFFFAOYSA-N
Compound NameSapitinib
Canonical SMILESCNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)9
Pfam Stratification Cross-Family
Avg pChEMBL7.12
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB12183
Drug NameSapitinib
CAS Number848942-61-0
Groups investigational
ATC Codes nan
DescriptionSapitinib has been used in trials studying the treatment and basic science of Neoplasms, Breast Cancer, Breast Neoplasms, Metastatic Cancer, and Metastatic Breast Cancer, among others.

Categories: Heterocyclic Compounds, Fused-Ring
Cross-references: BindingDB: 50437353 ChEBI: 132986 CHEMBL2408045 ChemSpider: 9663133 PubChem:11488320 PubChem:347828469 ZINC: ZINC000034587071
Target Activities (9)
Target Gene Organism Category Pfam pChEMBL Type Source
P00533 EGFR Homo sapiens Human PF00757 PF14843 PF07714 PF01030 PF21314 8.4 IC50 ChEMBL;BindingDB
P21860 ERBB3 Homo sapiens Human PF00757 PF14843 PF07714 PF01030 8.4 IC50 ChEMBL;BindingDB
P04626 ERBB2 Homo sapiens Human PF00757 PF14843 PF07714 PF01030 PF21314 7.8 IC50 ChEMBL;BindingDB
P21709 EPHA1 Homo sapiens Human PF14575 PF25599 PF01404 PF07699 PF00041 PF07714 PF00536 7.8 Kd ChEMBL
O14976 GAK Homo sapiens Human PF00069 PF10409 6.8 Kd ChEMBL
P07949 RET Homo sapiens Human PF00028 PF07714 PF17756 PF17812 PF17813 PF22540 6.4 Kd ChEMBL
P54760 EPHB4 Homo sapiens Human PF14575 PF25599 PF01404 PF07699 PF00041 PF07714 PF00536 6.2 Kd ChEMBL
O43353 RIPK2 Homo sapiens Human PF00619 PF07714 6.1 Kd ChEMBL
P54756 EPHA5 Homo sapiens Human PF14575 PF25599 PF01404 PF00041 PF07714 PF00536 6.1 Kd ChEMBL
DrugBank Target Actions (1)
Target Gene Target Name Action Type
P04626 ERBB2 Receptor tyrosine-protein kinase erbB-2 inhibitor targets